News

Patented Medicine Prices Review Board will hear evidence in the matter of the price of orphan drug Soliris

February 15, 2017

Proceedings to resume February 20, 2017 in Ottawa.


Patented Medicine Prices Review Board seeks applicants for Chairperson and Board member positions

February 13, 2017

Governor in Council selection processes underway.


Patented Medicine Prices Review Board will hear evidence in the matter of the price of orphan drug Soliris

January 11, 2017

Proceedings to begin in January 2017 in Ottawa.


Canada’s drug price watchdog issues decision in acne drug case

December 21, 2016

A Patented Medicine Prices Review Board (PMPRB) Hearing Panel issued an Order on December 19, 2016 relating to the medicines Differin and Differin XP, manufactured and marketed in Canada by Galderma Canada Inc. (Galderma).


Canada’s drug price watchdog welcomes Vice-chairperson of the Board for a second term

November 23, 2016

Dr. Mitchell Levine reappointed as Vice-chairperson of the Patented Medicine Prices Review Board


PAGE 1 - 2 - 3 - 4 - 5  NEXT 25  LAST 5 
Date modified: